Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Yizhou (Shanghai) Biological Medicine Co. Ltd. is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This prosecution involves 1 distinct examiner and is situated within a distinct art unit. This concentration indicates a specific technical focus for the company's current intellectual property strategy.
The busiest examiner is KOROTCHKINA, LIOUBOV G, who handles the busiest examiner pending office action. Since the portfolio is limited to a distinct art unit, the technical evaluation is consistent across the active filings. Practitioners can focus on the requirements of this examiner to navigate the current prosecution cycle effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOROTCHKINA, LIOUBOV G | 1 | 29.0% | +64.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17579510 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | KOROTCHKINA, LIOUBOV G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17579510 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | KOROTCHKINA, LIOUBOV G | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17579510 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | KOROTCHKINA, LIOUBOV G | 1653 | §103 | Final Rejection | — | Pending | Jan 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialYizhou (Shanghai) Biological Medicine Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lioubov G Korotchkina has the most, with 1 of Yizhou (Shanghai) Biological Medicine Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
